olmesartan has been researched along with methotrexate in 6 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
---|---|---|---|---|---|
841 | 185 | 554 | 41,593 | 5,666 | 11,969 |
Protein | Taxonomy | olmesartan (IC50) | methotrexate (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 1.8 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
Thymidylate synthase | Homo sapiens (human) | 0.343 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
Folate receptor beta | Homo sapiens (human) | 0.1585 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Reduced folate transporter | Homo sapiens (human) | 0.012 | |
Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Brito, GA; Cavalcanti, Pde F; de Araújo, AA; de Araújo, RF; de Medeiros, CA; de Moura Freire, MA; Freire, MA; Reinaldo, MP | 1 |
Araújo, TE; Borba, PB; da Silva, AI; de Araújo Júnior, RF; de Araújo, AA; de Souza, FH; Nogueira, AC; Saldanha, TS | 1 |
1 review(s) available for olmesartan and methotrexate
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
5 other study(ies) available for olmesartan and methotrexate
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Bacteremia; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Down-Regulation; Imidazoles; Immunohistochemistry; Interleukin-1beta; Intestine, Small; Leukocytosis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Methotrexate; Mucositis; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Tetrazoles; Tumor Necrosis Factor-alpha; Up-Regulation | 2014 |
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Diarrhea; Disease Models, Animal; Imidazoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Mucositis; Neoplasms; Olmesartan Medoxomil; Rats, Wistar; Sucrose; Tetrazoles; Tumor Necrosis Factor-alpha; Weight Loss | 2015 |